ENZYFERM AS

Signals

3 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−299k kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−1,3 mill kr).
• ◆ Nylig endring 2026-07-29 Aksjekapital registrert 2026-07-29.

ENZYFERM AS is registered as a limited company in Hamar, Innlandet with organisation number 932763737. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2023. Registered share capital is NOK 1.0m, divided into 300000 shares. The company's stated purpose is: “Utvikle, selge og markedsføre teknologi og produkter basert på mikrobiologisk materiale.”. The most recent filed accounts, for the 2024 financial year, show NOK 690,000 in revenue and NOK −1.3m in operating profit.

Key figures · 2024

Revenue

NOK 690,000

Operating profit

NOK −1.3m

Equity

NOK −299,000

Financial health · 2024

Liquidity

1.75

Good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-18.3%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns ENZYFERM AS?

ENZYFERM HOLDING AS

100.0%

ENZYFERM AS

NOK 690,000 rev. · NOK −1.3m profit

ENZYFERM AS has 1 registered shareholder:

• ENZYFERM HOLDING AS 100.0%

All shareholders and roles →

Group structure

ENZYFERM AS er morselskap for 1 datterselskap:

• ENZYFERM AS 100%

Frequently asked questions about ENZYFERM AS

Who owns ENZYFERM AS?

ENZYFERM HOLDING AS is the largest registered owner, with 100.0%.

What is the revenue of ENZYFERM AS?

ENZYFERM AS had revenue of NOK 690,000 in 2024.

Who is the general manager of ENZYFERM AS?

Leif Christian Hanstad is registered as general manager of ENZYFERM AS.

Where is ENZYFERM AS based?

ENZYFERM AS has its business address in Hamar.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.